Yao, F., and Z. Shi. “MiR-16 Is Promising to Be a Therapy Target to Alleviate Atherosclerosis”. Diagnostics and Therapeutics, vol. 2, no. 1, Jan. 2023, pp. 13-15, doi:10.55976/dt.22023116113-15.